Humoral and Cellular Responses to a Non-Adjuvanted Monovalent H1N1 Pandemic Influenza Vaccine in Hospital Employees

BMC Infectious Diseases - United Kingdom
doi 10.1186/1471-2334-13-544
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Responses of Aboriginal Canadians to Adjuvanted Pandemic (H1N1) 2009 Influenza Vaccine

CMAJ
Medicine
2011English

Risk of Presentation to Hospital With Epileptic Seizures After Vaccination With Monovalent AS03 Adjuvanted Pandemic a/H1n1 2009 Influenza Vaccine (Pandemrix): Self Controlled Case Series Study

British Medical Journal
Medicine
2012English

Safety of AS03-adjuvanted Split-Virion H1N1 (2009) Pandemic Influenza Vaccine: A Prospective Cohort Study

BMJ Open
Medicine
2013English

Clinical Features of Narcolepsy in Children Vaccinated With AS03 Adjuvanted Pandemic a/H1n1 2009 Influenza Vaccine in England

Developmental Medicine and Child Neurology
Child HealthDevelopmental NeurosciencePediatricsPerinatologyNeurology
2014English

Seroprevalence of Pandemic H1N1 Antibody Among Health Care Workers in Hong Kong Following Receipt of Monovalent 2009 H1N1 Influenza Vaccine

PLoS ONE
Multidisciplinary
2011English

Influenza Vaccination in Children Primed With MF59®-adjuvanted or Non-Adjuvanted Seasonal Influenza Vaccine

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2015English

Influenza a/H1n1 MF59 Adjuvanted Vaccine in Pregnant Women and Adverse Perinatal Outcomes: Multicentre Study

British Medical Journal
Medicine
2013English

Safe Vaccination of Patients With Egg Allergy With an Adjuvanted Pandemic H1N1 Vaccine

Pediatrics
Child HealthPediatricsPerinatology
2011English

Risk Factors and Outcomes Among Children Admitted to Hospital With Pandemic H1N1 Influenza

CMAJ
Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy